Related references
Note: Only part of the references are listed.limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor
Charles H. C. Halsey et al.
BMC VETERINARY RESEARCH (2014)
Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo
Phyllis Fung-Yi Cheung et al.
CANCER CELL INTERNATIONAL (2014)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Reading between the lines: molecular characterization of five widely used canine lymphoid tumour cell lines
E. L. Seiser et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2013)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
DRUG DISCOVERY Cell lines battle cancer
John N. Weinstein
NATURE (2012)
Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior
Benoit Hedan et al.
BMC CANCER (2011)
Characterization of Canine Osteosarcoma by Array Comparative Genomic Hybridization and RT-qPCR: Signatures of Genomic Imbalance in Canine Osteosarcoma Parallel the Human Counterpart
Andrea Y. Angstadt et al.
GENES CHROMOSOMES & CANCER (2011)
Polymerase chain reaction-based species verification and microsatellite analysis for canine cell line validation
Liza E. O'Donoghue et al.
JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Epidermal growth factor enhances the malignant phenotype in canine mammary carcinoma cell lines
K. C. Kennedy et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2011)
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2010)
Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
Cheryl A. London et al.
CLINICAL CANCER RESEARCH (2009)
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions
Martin L. Sos et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Modeling genomic diversity and tumor dependency in malignant melanoma
William M. Lin et al.
CANCER RESEARCH (2008)
Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors
K. A. Hahn et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2008)
Species identification in cell culture: a two-pronged molecular approach
Jason K. Cooper et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Share Paper
